Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
Cancer survival in Europe: good results for Italy
Italy is one of the best countries in Europe for cancer survival, as emerges from EUROCARE, a project started in 1989 under the initiative of two Italian research institutes, Fondazione IRCCS Istituto Nazionale Tumori (INT) in Milan and Istituto Superiore di Sanità (ISS) in Rome, with the participation of a large number of Cancer Registries throughout Europe. As we can read on EUROCARE website, “the aims of the study are: to